Male/female, n (%) |
13/4 (76/24) |
16/4 (80/20) |
0.617 |
Age (year), median (IQR) |
52 (50.5-62) |
59 (49.8-69) |
0.414 |
Days from onset of symptoms-to-hospitalization, median (IQR) |
7
(4.5-7.5) |
6.5 (5-7) |
0.185 |
Fever (°F), median (IQR) |
101 (100-101.5) |
100.5 (100-101.75) |
0.912 |
Dry cough, n (%) |
17 (100) |
20 (100) |
0.001 |
Shortness of breath, n (%) |
14 (82.4) |
16 (80) |
0.855 |
Weakness, n (%) |
17 (100) |
20 (100) |
0.001 |
Diarrhea, n (%) |
3 (17.6) |
5 (25) |
0.289 |
Anosmia, n (%) |
11 (64.7) |
14 (70) |
0.516 |
Sore throat, n (%) |
9 (52.9) |
12 (60) |
0.043 |
Diabetes, n (%) |
14 (82.4) |
17 (85) |
0.675 |
Hypertension, n (%) |
13 (76.5) |
12 (60) |
0.043 |
CVD, n (%) |
6 (35.3) |
4 (20) |
0.052 |
Bronchial asthma, n (%) |
4 (23.5) |
6 (30) |
0.389 |
CKD, n (%) |
2 (11.8) |
3 (15) |
0.577 |
COPD, n (%) |
2 (11.8) |
3 (15) |
0.577 |
Severe obesity, n (%) |
2 (11.8) |
2 (10) |
0.740 |
Malignancy, n (%) |
1 (5.9) |
3 (15) |
0.075 |
PD, n (%) |
0 (0) |
2 (10) |
0.005 |
SpO2 (%), median (IQR) |
89 (87.5-90) |
89.5 (88-90) |
0.718 |
Respiratory rate, (breaths/min), median (IQR) |
22 (20.5-24) |
23
(21-24) |
0.825 |
PaO2/FiO2 (mmHg), median (IQR) |
240
(195.5-263.5) |
245 (193.8-262.3) |
0.010 |
Heart rate (beat/min), median (IQR) |
98 (85.5-105.5) |
94.5 (84.5-113) |
0.174 |
CRP (mg/L), median (IQR) |
43.5 (30-220) |
77.1 (40.9-211.5) |
0.946 |
Procalcitonin (ng/mL), median (IQR) |
0.12 (0.06-0.49) |
0.18
(0.07-0.86) |
0.062 |
WBC (K/µL), median (IQR) |
6.3 (4.7-10) |
8 (6.3-14.3) |
0.021 |
Neutrophils (%), median (IQR) |
87.6 (79.4-92.1) |
82.5 (76.8-88.1) |
0.657 |
Lymphocytes (%), median (IQR) |
13.9 (11.9-15.8) |
12.2 (8.2-14.5) |
0.006 |
Platelet (K/µL), median (IQR) |
186 (128-255) |
175 (133.3-245.3) |
0.605 |
D-Dimer (mg /L FEU), median (IQR) |
2.7 (1.7-7.6) |
2 (1.5-3.2) |
0.018 |
Serum Ferritin (ng/mL), median (IQR) |
434 (293.5-543.5) |
470
(361.3-604.8) |
0.227 |
LDH ((U/L), median (IQR) |
272 (216-404.5) |
334 (295-390.5) |
0.009 |
Creatinine (mg/dL), median (IQR) |
0.9 (0.8-1) |
0.9 (0.7-1.1) |
0.210 |
ALT (U/L), median (IQR) |
34 (29-57) |
44 (35-54) |
0.13 |
AST (U/L), median (IQR) |
35 (25.5-49) |
40 (29.5-58.8) |
0.349 |
MEWS, median (IQR) |
3 (2-3) |
3 (2-3) |
0.476 |